Documents & Downloads

Other Forms

Form	MW
Vapiprost This page	477.63
Vapiprost hydrochloride	514.10

Vapiprost

Thromboxane A2 Receptor Antagonist

Vapiprost is a thromboxane A2 receptor (TXA2 receptor) antagonist that effectively inhibits thromboxane-mediated platelet aggregation and ATP release. It demonstrates a potent inhibitory effect on the aggregation induced by U-46619, collagen, or arachidonic acid (AA) with an IC50 of less than 2.1×10^-8 M. Vapiprost is utilized in research applications focused on cardiovascular studies and platelet function, contributing valuable insights into thromboxane signaling pathways.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Antagonist
CAS Number	85505-64-2
Applications	Thromboxane A2 Receptor Antagonist
Formula	C₃₀H₃₉NO₄
Molecular Weight	477.63
Synonyms	GR 32191
SMILES	OC(CC/C=C\CC[C@@H]1[C@@H](N2CCCCC2)[C@H](C[C@@H]1OCC3=CC=C(C4=CC=CC=C4)C=C3)O)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.